NCI and Cancer Research UK have awarded $100 million in total funding through the Cancer Grand Challenges program, supporting research into solid tumors in children, cachexia, extrachromosomal DNA, and tumor development.
As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.
